AKT activation is implicated in poor HCC prognosis [134,135,136], whereas AKT inhibition decreases in vitro growth and orthotopic implantation of HCC cells [137,138,139,140,141]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.